Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Survival of glioma patients in relation to mobile phone use in Denmark, Finland and Sweden

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Diagnostics and treatment of diffuse intrinsic pontine glioma: where do we stand?

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Toxicity and efficacy of lomustine and bevacizumab in recurrent glioblastoma patients

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Treatment and survival of glioblastoma patients in Denmark: The Danish Neuro-Oncology Registry 2009-2014

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Sexual Function and Quality of Life in a National Cohort of Survivors of Bilateral Testicular Cancer

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Clinical characteristics and quality of life, depression, and anxiety in adults with neurofibromatosis type 1: A nationwide study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Clinical and histopathological predictors of outcome in malignant meningioma

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Glioma risk associated with extent of estimated European genetic ancestry in African Americans and Hispanics

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Psychological stress in long-term testicular cancer survivors: a Danish nationwide cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Ann Olsson
  • Liacine Bouaoun
  • Anssi Auvinen
  • Maria Feychting
  • Christoffer Johansen
  • Tiit Mathiesen
  • Beatrice Melin
  • Anna Lahkola
  • Suvi Larjavaara
  • Anne-Sophie Villegier
  • Graham Byrnes
  • Isabelle Deltour
  • Joachim Schüz
Vis graf over relationer

PURPOSE: Gliomas are the most common cancer of the brain, with a poor prognosis in particular for glioblastoma. In 2014, a study suggested reduced survival in relation to latency of mobile phone use among glioblastoma patients. A joint epidemiological/experimental project to study effects of RF-EMF on tumor development and progression was established. The current analysis relates to the epidemiological part and addresses whether pre-diagnostic mobile phone use was associated with survival among glioma patients.

METHODS: Glioma cases (n = 806) previously enrolled in a collaborative population-based case-control study in Denmark, Finland and Sweden were followed up for survival. Vital status, date of death, date of emigration, or date last known to be alive was obtained based on registry linkages with a unique personal ID in each country. Cox regression models were used to calculate hazard ratios (HR) and 95% confidence intervals (CI) stratified by country. Covariates investigated were sex, age, education, histology, treatment, anatomic location and marital status.

RESULTS: No indication of reduced survival among glioblastoma patients was observed for various measures of mobile phone use (ever regular use, time since start of regular use, cumulative call time overall or in the last 12 months) relative to no or non-regular use. All significant associations suggested better survival for mobile phone users. Results were similar for high-grade and low-grade gliomas.

CONCLUSIONS: We found no evidence of reduced survival among glioma patients in relation to previous mobile phone use.

OriginalsprogEngelsk
TidsskriftJournal of Neuro-Oncology
Vol/bind141
Udgave nummer1
Sider (fra-til)139-149
Antal sider11
ISSN0167-594X
DOI
StatusUdgivet - jan. 2019

ID: 55714718